| Financial Year |
March 31 2023 |
| Monetary Funds |
81,862,352.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
9,390,465.72 |
| Accounts Receivable |
23,395,129.01 |
| Advances to Suppliers |
60,565,286.04 |
| Other Receivables |
9,424,187.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,516,533.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,679,052.04 |
| Total Current Assets |
326,033,006.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
24,238,660.68 |
| Investment Properties |
-- |
| Fixed Assetes |
1,240,332,454.25 |
| Under-construction Projects |
27,925,523.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
124,169,828.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
61,535,837.46 |
| Deferred Income Tax Assets |
44,428,147.08 |
| Other Non-Current Assets |
176,686.00 |
| Sub-Total of Non-Current Assets |
1,559,937,217.99 |
| Total Assets |
1,885,970,224.07 |
| Short-Term Loans |
154,705,280.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
250,095,773.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,484,946.38 |
| Taxes Payable |
13,351,519.96 |
| Interest Payable |
-- |
| Dividend Payable |
575,392.79 |
| Other payables |
97,993,251.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,550,226.01 |
| Other Current Liabilities |
4,563,663.73 |
| Sub-Total of Current Liabilities |
573,759,166.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
51,504,402.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,909,625.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
81,614,667.28 |
| Total Liabilities |
655,373,834.13 |
| Paid-In Capital(Or Share Stock) |
1,016,524,240.00 |
| Capital Surplus |
1,761,908,266.20 |
| Surplus Reserve |
56,144,485.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,946,126,980.90 |
| Minority Stockholder's Interest |
337,525,398.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
893,070,991.49 |
| Owner's Equity（Stockholder's Equity） |
1,230,596,389.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,885,970,224.07 |
